Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

19.51
Delayed Data
As of Jan 20
 +0.61 / +3.23%
Today’s Change
18.16
Today|||52-Week Range
22.98
+0.77%
Year-to-Date
Better Buy: GlaxoSmithKline PLC vs. Johnson & Johnson
Jan 21 / MotleyFool.com - Paid Partner Content
4 Signs Glaxo's Turnaround Is Taking Hold
Jan 13 / MotleyFool.com - Paid Partner Content
5 Drugs That Are Way Cheaper in Canada
Jan 21 / MotleyFool.com - Paid Partner Content
Hoertkorn Richard Charles Buys Citigroup Inc, GlaxoSmithKline PLC, Wells Fargo & Co, ...
Jan 11 / GuruFocus News - Paid Partner Content
Is GlaxoSmithKline (GSK) a Great Stock for Value Investors?
Jan 20 / Zacks.com - Paid Partner Content
Merck: Keytruda+Chemo Gets Priority Review for Lung Cancer
Jan 11 / Zacks.com - Paid Partner Content
Frontrunning: January 20
Jan 20 / Investing Channel - Paid Partner Content
3 Big Reasons (and 8 Smaller Ones) to Buy Ionis Pharmaceuticals Stock
Jan 10 / MotleyFool.com - Paid Partner Content
Flood of News Presents Buying Opportunity
Jan 17 / GuruFocus News - Paid Partner Content
Bristol-Myers, GeneCentric Tie Up for Opdivo Biomarker Study
Jan 09 / Zacks.com - Paid Partner Content
Is GlaxoSmithKline's Stock a Bargain After Dropping 4.8% in 2016?
Jan 13 / MotleyFool.com - Paid Partner Content
4 Reasons Why Pfizer (PFE) Could be a Great Pick in 2017
Jan 04 / Zacks.com - Paid Partner Content